Mercado terapéutico de verrugas: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPRE00024332
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 401
Buy Now

El mercado de terapias para las verrugas se valoró en 1.829,54 millones de dólares en 2021 y se estima que crecerá a una tasa compuesta anual del 3,4% de 2021 a 2028.

El crecimiento del mercado de terapias para las verrugas se atribuye al aumento prevalencia de infecciones por el virus del papiloma humano y recurrencia de verrugas genitales, y desarrollo de nuevos productos. Sin embargo, el escenario de diagnóstico deficiente en los países de bajos ingresos restringe el crecimiento del mercado. Las verrugas son crecimientos de la piel causados por el virus del papiloma humano (VPH). Hay más de 60 tipos de VPH y varios de ellos tienden a causar verrugas en la piel. Aunque los tratamientos tópicos probablemente podrían resolver el problema de las verrugas en unas pocas semanas con efectos secundarios mínimos, es posible que no sean efectivos todo el tiempo. Por lo tanto, la crioterapia con nitrógeno líquido es una opción adecuada para el tratamiento, donde la tasa de curación es del 60 al 90 % y la tasa de recurrencia es inferior al 10 al 20 %.

En los EE. UU., la demanda de procedimientos de tratamiento de las verrugas se ha reducido debido a al cambio de enfoque en el COVID-19. La pandemia ha estado causando estragos en las cadenas de suministro globales, los mercados de consumo y las economías en su conjunto. Como resultado, las medidas implementadas por los gobiernos de todo el mundo han tenido un impacto negativo en el crecimiento del mercado de terapias para las verrugas.

regiones lucrativas para el mercado de terapias para las verrugas


Perspectivas del mercado
La creciente prevalencia de infecciones por el virus del papiloma humano y la recurrencia de las verrugas genitales impulsan el crecimiento del mercado terapéutico contra las verrugas
Las verrugas son causadas por varias cepas de virus del papiloma humano (VPH), y diferentes cepas causan verrugas en diferentes partes del cuerpo. Las personas sanas que entran en contacto con las verrugas pueden contraer la infección. Según los Centros para el Control y la Prevención de Enfermedades (CDC), en 2018, ~20% de la población, es decir, ~42,5 millones de personas, en los EE. UU. tenía infecciones de transmisión sexual (ITS). Además, antes de la vacuna contra el VPH, las verrugas genitales afectaban anualmente a entre 340.000 y 360.000 mujeres y hombres en Estados Unidos. Además, la tasa de recurrencia de las verrugas genitales es alta. Según el Centro Nacional de Información Biotecnológica (NCBI), se espera que aproximadamente el 30% del total de casos de verrugas en todo el mundo retrocedan dentro de los primeros cuatro meses de la infección. Además, las infecciones por VPH provocan cáncer de cuello uterino, y el cáncer de cuello uterino es el cuarto cáncer más común entre las mujeres a nivel mundial. Según la Organización Mundial de la Salud (OMS), en 2018 se registraron ~570.000 nuevos casos de cáncer de cuello uterino con alta prevalencia en países de bajos ingresos. Por lo tanto, un aumento en la prevalencia de las infecciones por VPH, lo que lleva a un aumento en los casos de verrugas, y la alta tasa de recurrencia de las verrugas están impulsando el crecimiento del mercado de terapias para las verrugas.

Información basada en el tipo
Basado en el tipo , el mercado terapéutico de las verrugas se segmenta aún más en verrugas comunes, verrugas genitales, verrugas planas y otras. El segmento de las verrugas comunes tiene la mayor cuota de mercado. Sin embargo, se prevé que el segmento de verrugas genitales registre la CAGR más alta durante 2021-2028. Las verrugas genitales se refieren a una infección de transmisión sexual que generalmente es causada por el VPH. La creciente prevalencia de las ETS y los crecientes esfuerzos de investigación y desarrollo para desarrollar opciones de tratamiento de las verrugas genitales impulsarían el crecimiento del mercado de este segmento en los próximos años.

Mercado terapéutico de las verrugas, por tipo: 2021 y 2028

Información basada en el tratamiento
Según el tratamiento, el mercado terapéutico de las verrugas se segmenta aún más en destrucción física, inmunomodulación y destrucción química. El mercado de la destrucción física se segmenta aún más en crioterapia, extirpación quirúrgica y tratamiento con láser. La inmunomodulación se subdivide en interferones, retinoides y zinc. El segmento de destrucción química se divide a su vez en bleomicina, cantaridina, ácido salicílico y otros. El segmento de destrucción física tiene la mayor participación del mercado de terapias para las verrugas y se prevé que registre la CAGR más alta del mercado durante el período de pronóstico.

Información basada en el usuario final
Basado en el usuario final, las verrugas El mercado terapéutico está segmentado en hospitales, atención domiciliaria, clínicas especializadas y otros. El segmento de hospitales tiene la mayor cuota de mercado. Sin embargo, se estima que el segmento de atención domiciliaria registrará la CAGR más alta durante el período de pronóstico. El crecimiento proyectado del mercado para este segmento se puede atribuir al creciente número de hospitales en todo el mundo y al rápido crecimiento del número de procedimientos quirúrgicos.
br>Información estratégica
Las empresas que operan en el mercado terapéutico de las verrugas están adoptando la estrategia de innovación de productos para satisfacer las cambiantes demandas de los clientes en todo el mundo, lo que también les permite mantener su marca en el mercado global.

Mercado terapéutico de las verrugas - ndash; por tipo

  • Verrugas comunes
  • Verrugas genitales
  • Verrugas planas
  • Otras

Mercado terapéutico de las verrugas: por Tratamiento

  • Destrucción Física
    • Crioterapia
    • Extirpación Quirúrgica
    • Tratamiento con Láser
  • Inmunomodulación
    • Interferones
    • Retinoides
    • Zinc
  • Destrucción química
      < li>Bleomicina
    • Cantaridina
    • Ácido salicílico
    • Otros

Mercado terapéutico de las verrugas - por usuario final

  • Hospitales
  • Atención domiciliaria
  • Clínicas especializadas
  • Otros

Mercado terapéutico de las verrugas: por Geografía

  • América del Norte
    • Estados Unidos
    • Canadá
    • México
  • < li>Europa
    • Francia
    • Alemania
    • Italia
    • Reino Unido
    • España
    • Resto de Europa
  • Asia Pacífico (APAC)
    • China
    • India
    • Corea del Sur
    • Japón
    • Australia
    • Resto de APAC
  • Oriente Medio y África (MEA)
    • Sudáfrica
    • Arabia Saudita
    • EAU
    • Resto de MEA
  • América del Sur y Central (SCAM )
    • Brasil
    • Argentina
    • Resto de ESTAFA

 

Perfiles de empresas

  • Bausch Health Companies Inc.      
  • Nielsen BioSciences, Inc.    
  • Euro Vital Pharma GmbH    
  • Cipla Inc. .     
  • Koninklijke Utermöhlen NV           
  • Novan, Inc.        
  • Scholl's Wellness Company           
  • TEVA PHARMACEUTICAL INDUSTRIES LTD          
  • Verrica Pharmaceuticals Inc.        
  • GlaxoSmithKline plc.      
  • AIM ImmunoTech Inc
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are warts therapeutics?

Warts are skin growth caused by the human papillomavirus (HPV). There are more than 60 types of HPV, some of which tend to cause warts on the skin. Topical treatments could probably resolve the issue of warts in a few weeks with minimal side effects. Topical treatment of may not be effective all the time. Hence, cryotherapy with liquid nitrogen is a suitable option for treatment, where cure rate is 60% to 90% with less than 20% to 10% recurrence rate.

What are the driving factors for the Warts Therapeutics market across the globe?

The factors that are driving growth of the market are rising prevalence of human papillomavirus infections and recurrence of genital warts and new product developments.

Who are the developments carrying out by major players in the warts therapeutics market?

Various companies have made organic growth strategies in the warts therapeutics market. Some of the activities undertaken by the company, which have promoted its growth are, launches, enhancements and expansion & relocation activities. Companies such as Nielsen BioSciences, Inc, TEVA PHARMACEUTICAL INDUSTRIES LTD amongst others are some of the companies that have been implementing various organic strategies that have helped the growth of the company.

Which region is dominated the warts therapeutics market?

North America dominates the global warts therapeutics market due to factors such as rising prevalence of HPV, increasing product launches, well-developed healthcare facility centres equipped with modern-age equipment and instruments.

Which segment is growing at the highest CAGR in the Warts Therapeutics market?

The physical destruction segment is growing at the highest CAGR owing to availability of diagnostic devices and ease offered by these devices for diagnosis of various disorders.

Which region is the fastest growing in the Warts Therapeutics market?

Asia Pacific is expected to be the fastest growing region in the warts therapeutics market. The growth of the market in this region is primarily due to supportive government initiatives and research in the field of HPV infection.

The List of Companies - Warts Therapeutics Market

  1. Bausch Health Companies Inc.            
  2. Nielsen BioSciences, Inc.        
  3. Euro Vital Pharma GmbH        
  4. Cipla Inc.       
  5. Koninklijke Utermöhlen NV      
  6. Novan, Inc.    
  7. Scholl's Wellness Company    
  8. TEVA PHARMACEUTICAL INDUSTRIES LTD               
  9. Verrica Pharmaceuticals Inc.    
  10. GlaxoSmithKline plc.              
  11. AIM ImmunoTech Inc

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports